RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 42 filers reported holding RECRO PHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $11,439 | +208.2% | 10,591 | 0.0% | 0.00% | +100.0% |
| Q4 2023 | $3,712 | -25.3% | 10,591 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $4,968 | -57.4% | 10,591 | -0.0% | 0.00% | -66.7% |
| Q2 2023 | $11,651 | -7.6% | 10,592 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $12,604 | -20.1% | 10,592 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $15,782 | -21.1% | 10,592 | -12.4% | 0.00% | -20.0% |
| Q3 2022 | $20,000 | +100.0% | 12,096 | 0.0% | 0.01% | +150.0% |
| Q2 2022 | $10,000 | -64.3% | 12,096 | -22.5% | 0.00% | -60.0% |
| Q1 2022 | $28,000 | +3.7% | 15,608 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $27,000 | -15.6% | 15,608 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $32,000 | -11.1% | 15,608 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $36,000 | – | 15,608 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 3,510,000 | $6,318,000 | 5.40% |
| Cowen Prime Advisors LLC | 4,162,500 | $7,493,000 | 3.15% |
| Athyrium Capital Management, LP | 2,202,420 | $3,964,000 | 1.41% |
| AWM Investment Company, Inc. | 5,081,901 | $9,147,000 | 1.18% |
| Parkman Healthcare Partners LLC | 671,817 | $1,209,000 | 0.35% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 799,841 | $1,440,000 | 0.18% |
| Rubric Capital Management LP | 1,076,587 | $1,938,000 | 0.07% |
| TITLEIST CAPITAL, LLC | 180,093 | $324,000 | 0.06% |
| Clear Harbor Asset Management, LLC | 266,972 | $481,000 | 0.06% |
| Frontier Wealth Management LLC | 64,605 | $2,701,000 | 0.03% |